{"schema":"hottub-news/story/v1","story":"st_3fplrlripfn3f2yp56qa","title":"Ozempic, Wegovy and Zepbound get new FDA warning over rare condition","title_en":"Ozempic, Wegovy and Zepbound get new FDA warning over rare condition","outlets":5,"brief":null,"page":"https://hottub.news/stories/ozempic-wegovy-mounjaro-face-new-fda-warning-over-potential-risk-of-3fplrlripf","count":5,"items":[{"id":"n_hw262zikkzds6kxcxhcq","seq":9473174,"kind":"article","title":"Ozempic, Wegovy and Zepbound get new FDA warning over rare condition","url":"https://www.cleveland.com/news/2026/11/fda-adds-new-warning-to-popular-weight-loss-drugs-what-patients-should-know.html","summary":"The FDA is requiring new warnings for GLP-1 drugs including Ozempic, Wegovy, Mounjaro and Zepbound over a potential increased risk of a rare eye condition that can cause permanent vision loss.","published":"2026-11-10T14:33:40Z","seen":"2026-11-10T14:39:15Z","lang":"en","country":"US","source":{"id":"kite-cleveland-com-2fd336","name":"cleveland.com","domain":"cleveland.com","outlet":{"wikidata":"Q286036","name":"The Plain Dealer","type":"newspaper","country":"US","designations":["newspaper"]}},"via":"kite-cleveland-com-2fd336","topics":["ohio"],"authors":["Chris Pugh"],"image":"https://www.cleveland.com/resizer/v2/NIDRW23AXJDG7NVOXXFDF5RRS4.jpg?auth=affa027c725648bbccd09b8de8c5efa887fab1cfad5e200f883f9a60fb3a4725&height=1200&smart=true","story":"st_3fplrlripfn3f2yp56qa","category":"health","category_p":0.5199999809265137,"sentiment":"neutral","tone":-0.3700000047683716,"political":0.05999999865889549},{"id":"n_ctimbnyruyz665jiegha","seq":9483396,"kind":"article","title":"Ozempic, Wegovy and Zepbound get new FDA warning over rare condition","url":"https://www.mlive.com/news/2026/11/fda-adds-new-warning-to-popular-weight-loss-drugs-what-patients-should-know.html","summary":"People taking popular weight-loss and diabetes drugs are getting a new safety warning. The Food and Drug Administration is requiring all GLP-1 drugs …","published":"2026-11-10T14:33:40Z","seen":"2026-11-10T15:14:00Z","lang":"en","country":"US","source":{"id":"kite-flipboard-com-d02eac","name":"flipboard.com","domain":"flipboard.com","outlet":{"wikidata":"Q1168317","name":"Flipboard","type":"website","designations":["aggregator","fediverse app","social bookmarking","website"]}},"via":"kite-flipboard-com-d02eac","topics":["michigan","wegovy","ozempic","weight-loss medications","fda","u.s. dept. of health"],"authors":["author"],"image":"https://ic-cdn.flipboard.com/mlive.com/7ddea1548f38ccf3f7a8206089bd666719738470/_xlarge.jpeg","story":"st_3fplrlripfn3f2yp56qa","category":"health","category_p":0.5199999809265137,"sentiment":"neutral","tone":-0.3700000047683716,"political":0.05999999865889549},{"id":"n_awrxdvcneocufiiehfdq","seq":9491258,"kind":"article","title":"Ozempic, Wegovy and Zepbound get new FDA warning over rare condition","url":"https://www.silive.com/nation/2026/11/fda-adds-new-warning-to-popular-weight-loss-drugs-what-patients-should-know.html","summary":"The FDA is requiring new warnings for GLP-1 drugs including Ozempic, Wegovy, Mounjaro and Zepbound over a potential increased risk of a rare eye condition that can cause permanent vision loss.","published":"2026-11-10T14:33:40Z","seen":"2026-11-10T15:40:36Z","lang":"en","country":"US","source":{"id":"kite-silive-com-08fc64","name":"silive.com","domain":"silive.com","outlet":{"wikidata":"Q737529","name":"Staten Island Advance","type":"newspaper","country":"US","designations":["newspaper"]}},"via":"kite-silive-com-08fc64","topics":["new-york-city"],"authors":["Chris Pugh"],"image":"https://www.silive.com/resizer/v2/NIDRW23AXJDG7NVOXXFDF5RRS4.jpg?auth=affa027c725648bbccd09b8de8c5efa887fab1cfad5e200f883f9a60fb3a4725&height=1200&smart=true","story":"st_3fplrlripfn3f2yp56qa","category":"health","category_p":0.5199999809265137,"sentiment":"neutral","tone":-0.3700000047683716,"political":0.05999999865889549},{"id":"n_ww2s4b2zxkokhizeidxq","seq":9318212,"kind":"article","title":"Ozempic, Wegovy to carry new FDA warning over rare risk of vision loss","url":"https://www.business-standard.com/health/ozempic-wegovy-to-carry-new-fda-warning-over-rare-risk-of-vision-loss-126111000081_1.html","published":"2026-11-10T05:21:24Z","seen":"2026-11-10T05:21:24Z","lang":"en","country":"IN","source":{"id":"business-standard.com","name":"business-standard.com","domain":"business-standard.com","outlet":{"wikidata":"Q2307816","name":"Business Standard","type":"newspaper","country":"IN","designations":["newspaper"]}},"via":"gdelt-gkg-english","topics":["economy","health"],"authors":["Business Standard"],"entities":[{"id":"Q47521958","name":"Ozempic","type":"other"},{"id":"Q133859283","name":"Wegovy","type":"other"},{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"story":"st_3fplrlripfn3f2yp56qa","category":"health","category_p":0.5299999713897705,"sentiment":"neutral","tone":-0.6499999761581421,"political":0.10000000149011612},{"id":"n_3fplrlripfn3f2yp56qa","seq":9289907,"kind":"article","title":"Ozempic, Wegovy, Mounjaro Face New FDA Warning Over Potential Risk Of Serious Vision Loss","url":"https://www.ndtvprofit.com/markets/ozempic-wegovy-mounjaro-face-new-fda-warning-over-potential-risk-of-serious-vision-loss-12305907","summary":"NAION is a condition caused by reduced blood flow to the optic nerve, which carries visual information from the eye to the brain. It can result in sudden, painless loss of vision in one eye and, in...","published":"2026-11-10T02:29:03Z","seen":"2026-11-10T03:11:00Z","lang":"en","country":"IN","source":{"id":"kite-feedburner-com-fcf7b7","name":"feedburner.com","domain":"feeds.feedburner.com"},"via":"kite-feedburner-com-fcf7b7","topics":["markets"],"story":"st_3fplrlripfn3f2yp56qa","category":"health","category_p":0.47999998927116394,"sentiment":"negative","tone":-0.6499999761581421,"political":0.10999999940395355}]}